GDC-0829

N/A

Report date: 2024/02/22 11:57:33
NME

Base Information

Drug NameGDC-0829
Drug Alias NameGDC-0829
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actiontype I signal peptidase inhibitors
Targetstype I signal peptidase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A